Promoter holding
64.27%
GL
Gujarat Life Sciences Private Limited - Due diligence report
A 360° intelligence report on Gujarat Life Sciences Private Limited: trust score, financial health, credit view, compliance, directors, grow…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Gujarat Life Sciences Private Limited — 360° Intelligence Report
Generated from MCA filings & public records90/100
Trust Score
Low Risk
Gujarat Life Sciences Private Limited is assessed as Low Risk with a Trust Score of 90/100. Gujarat Life Sciences Private Limited is an active private limited indian non-government company incorporated in 2000, operating in the Agriculture sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 16 Aug 2026 from the latest processed filings. Gujarat Life Sciences Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
90/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
85/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
90/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- Moderate gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 3 open (3.09 cr) · 5 satisfied (2.67 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 3 | 48.0 cr |
| State Bank Of India | 2 | 48.0 cr |
| Bank Of India | 3 | 48.0 cr |
Compliance Score: 85/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 1 court forum(s).
- Delayed payments to MSME suppliers disclosed (85 disclosure(s)).
- 4 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 90/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| MILIN KAIMAS MEHTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MAHESH HARIBHAI MEHTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ARJUN MAHESH MEHTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SHUBHRA ARJUN MEHTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 4 directors on the board.
- No disqualified or deactivated DINs.
- 1 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Key managerial personnel: ARJUN MAHESH MEHTA (Whole-time director) · SHUBHRA ARJUN MEHTA (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 90 · Distress 80
Growth signals & trust indicators
Steady revenue growth: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Asset base grew 61% - capacity expansion.
Net margin improved to 38%.
Operating for 26+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 1.42 in a year.
3 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 64.91 Lakh.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence85/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment92/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 3 open charge(s) of 3.09 cr already registered.
- Compliance record supports lending.
Investor view92/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 5 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2025
Last AGM held
Annual general meeting
29 Sep 2025
Director ceased
Nirja Amit Bhatt
05 Jun 2025
Charge created
Hdfc Bank Limited - 10.34 Lakh
31 Mar 2025
Latest balance sheet
Filed with ROC
28 Jan 2025
Charge created
Hdfc Bank Limited - 23.82 Lakh
30 Nov 2021
Director ceased
RAJESH MANOHARLAL UMATT
25 Dec 2017
Director ceased
AMIT ROHIT BHATT
21 Mar 2017
Director ceased
BHIKHAJI PHIROZE UDWADIA
18 May 2011
Charge satisfied
State Bank Of India
10 May 2011
Charge created
Hdfc Bank Limited - 2.75 cr
15 Jan 2010
Charge satisfied
Bank Of India
03 Aug 2009
Director ceased
MAHESH HARIBHAI MEHTA
30 Jul 2009
Charge created
State Bank Of India - 65.00 Lakh
14 Jul 2009
Charge created
State Bank Of India - 95.00 Lakh
01 Oct 2008
Director appointed
MAHESH HARIBHAI MEHTA (Director)
10
Key Observations
Auto-generated from the data aboveRevenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); board looks stable and experienced.
4 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
| Company | CIN | Location |
|---|---|---|
| Shree Pushkar Phoschem Private Limited | U24233RJ2009PTC078489 | Udaipur, Rajasthan, India |
| Nuova Sivam And Genver Coatings Private Limited | U51909DL2018PTC331248 | Delhi, Delhi, India |
| Govind Poy Oxygen Limited | L40200GA1972PLC000144 | Goa, Goa, India |
| Brukem Life Care | U24299GJ2021PTC121067 | Ahmedabad, Gujarat, India |
| Safex | U24299DL2021PTC379521 | Delhi, Delhi, India |
| Reachem Laboratory Chemicals Private Limited | U24117TN1991PTC021382 | Madras-58, Tamil Nadu, India |
| Linde | U40200KA2005PTC036482 | Bangalore, Karnataka, India |
| Sankur Pharmaceuticals Private Limited | U74120UP2016PTC076748 | Agra, Uttar Pradesh, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Gujarat Life Sciences Private Limited before audits and certifications: compliance score 85/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Gujarat Life Sciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Gujarat Life Sciences Private Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 90/100, distress signals and MSME payment-delay disclosures - know whether Gujarat Life Sciences Private Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Gujarat Life Sciences Private Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Gujarat Life Sciences Private Limited an active company?
Gujarat Life Sciences Private Limited has MCA status “Active” with a compliance score of 85/100 (Low Risk).
Is Gujarat Life Sciences Private Limited financially healthy?
Gujarat Life Sciences Private Limited has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Gujarat Life Sciences Private Limited?
Its overall Trust Score is 90/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Gujarat Life Sciences Private Limited?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 4 active director(s) are on record.
Does Gujarat Life Sciences Private Limited have loans or charges against its assets?
3 open charge(s) are registered against its assets, and 5 earlier charge(s) stand satisfied.
Is Gujarat Life Sciences Private Limited up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 85/100 (Low Risk).
Is it risky to lend to Gujarat Life Sciences Private Limited?
Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
